共 50 条
- [2] A Systematic Review and Meta-Analysis of Randomized Controlled Trials to Evaluate the Risk of Hematological Toxicities in Patients with Multiple Myeloma Treated with Daratumumab CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S242 - S243
- [9] Daratumumab-Related Pulmonary Toxicities in Patients with Multiple Myeloma: A Systematic Review and Meta-Analysis of Phase III Randomized Controlled Trials CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S242 - S242